Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

PATH initiates phase I trial of MCV-5 meningococcal conjugate vaccine

Aug. 22, 2016

Chinese clinical trial authorization for TaiGen's furaprevir

Aug. 19, 2016

NIAID funding supports testing of Kineta's broad-spectrum antivirals in preclinical Zika models

Aug. 19, 2016

Xenetic Biosciences starts collaboration with Excivion to develop Zika vaccine

Aug. 19, 2016

Quidel obtains FDA clearance to market Solana Trichomonas assay

Aug. 18, 2016

FDA grants orphan drug designation to Pulmatrix's PUR-1900

Aug. 18, 2016

Symbiomix Therapeutics accelerates commercial launch for Solosec

Aug. 18, 2016

Study adds to complexity of nasal flu vaccine picture

Aug. 17, 2016

Japan Tobacco seeks Japanese approval for emtricitabine/tenofovir alafenamide

Aug. 17, 2016

Eiger initiates phase II trial of pegylated interferon lambda for chronic HDV infection

Aug. 17, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 2, 2026.
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...